首页> 外国专利> 2-Sulfanyl-benzimidazole-4-carboxamide derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition containing the same as an active ingredient for the prevention and treatment of the diseases induced by the overactivation of PolyADP-ribosepolymerase-1

2-Sulfanyl-benzimidazole-4-carboxamide derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition containing the same as an active ingredient for the prevention and treatment of the diseases induced by the overactivation of PolyADP-ribosepolymerase-1

机译:2-硫烷基-苯并咪唑-4-羧酰胺衍生物或其药学上可接受的盐,其制备方法和包含其的药物组合物作为预防和治疗由PolyADP-核糖聚合酶-1过度活化引起的疾病的活性成分

摘要

The present invention represented by the general formula (1) 2-sulfanyl-benzimidazole-4-carboxamide derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, and containing the same as an active ingredient, a poly (ADP- ribose) polymerase -1 (PARP-1) a pharmaceutical for the prevention or treatment of diseases which are caused by actively relates to a composition, the present invention are the derivatives and to consume a large amount of ATP upon activation which results in cell damage and cell death enzyme PARP-1 strongly inhibited the bar, myocardial infarction, angina pectoris, arrhythmia, heart failure, stroke, , a brain trauma or ischemic disease and Parkinson's disease, including renal failure, Alzheimer's disease or preventing or treating neurodegenerative disorders, including the use of multiple sclerosis, also using a surgical therapy and thrombolytic agents, including coronary artery bypass surgery or percutaneous coronary angioplasty may be useful as cardioprotective medication use during treatment, such as reperfusion therapy. ; [Formula 1] ; (wherein, R 1 , R 2 , X and n are as defined in the specification same.)
机译:通式(1)表示的本发明的聚(ADP-核糖)聚合酶为2-硫烷基-苯并咪唑-4-羧酰胺衍生物或其药学上可接受的盐,其制备方法,并以其作为有效成分。 -1(PARP-1)预防或治疗由组合物引起的疾病的药物,本发明是衍生物,并且在活化时消耗大量ATP,这会导致细胞损伤和细胞死亡PARP-1酶强烈抑制棒,心肌梗塞,心绞痛,心律失常,心力衰竭,中风,脑外伤或局部缺血性疾病和帕金森氏病,包括肾衰竭,阿尔茨海默氏病或​​预防或治疗神经退行性疾病,包括使用多发性硬化症,也可以使用外科手术疗法和溶栓剂,包括冠状动脉搭桥手术或经皮冠状动脉成形术作为治疗期间使用的心脏保护药物,例如再灌注疗法。 ; [公式1] ; (其中,R 1 R 2 ,X和n与规范中的定义相同。)

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号